Feb 9 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2023 Dec 31, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.64 8.74 12.10
(-1.1 pct) (-8.6 pct) (-10.4 pct)
Operating loss 573 mln loss 767 mln loss 450 mln
Recurring loss 573 mln loss 742 mln loss 470 mln
Net loss 912 mln loss 810 mln loss 2.34
EPS loss 241.17 yen loss 214.40 yen loss 618.80 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T